If you've ever felt dismissed, misdiagnosed, or exhausted from trying to get help for PMDD, you're not alone — and this study captures exactly those experiences.
Researchers at Emory University interviewed 32 people with PMDD in the U.S. to understand what it's really like to navigate the healthcare system with this condition. What they found was striking: on average, participants waited over 5 years from the time their symptoms started to getting an official diagnosis. Many had been living with PMDD for more than 17 years. Nearly two-thirds first figured out they had PMDD on their own before a doctor confirmed it. Nine participants were initially misdiagnosed — often with bipolar disorder or borderline personality disorder — and almost everyone in the study experienced suicidal thoughts as a regular part of their cycle.
The study identified three main types of barriers. Societal barriers included the widespread belief that menstrual suffering is "normal," which made people hesitant to seek help. Provider barriers included doctors dismissing symptoms, not being familiar with PMDD, or refusing to look at symptom-tracking records patients brought in. Patient barriers included losing trust in doctors after negative experiences, which made it harder to keep seeking care. Even after getting diagnosed, many participants had to start the process over with every new doctor they saw.
Most participants were prescribed SSRIs or birth control as first-line treatments, but many found these only partially helpful. Those who eventually received second- or third-line treatments — like hormonal or surgical menopause — reported much greater relief. Some turned to alternative approaches like acupuncture or supplements after feeling let down by traditional medicine. The researchers concluded that the burden of diagnosis and treatment falls heavily on patients themselves, and that much more provider education and care coordination is needed.
Key findings
- The average time from PMDD symptom onset to official diagnosis was 5.6 years, with participants suffering PMDD for a mean of 17.43 years
- 19 out of 32 participants self-diagnosed their PMDD before receiving an official diagnosis from a provider
- 9 participants experienced misdiagnoses, most commonly bipolar disorder or borderline personality disorder
- Almost all 32 participants experienced suicidal ideation as part of their monthly PMDD symptomology, and 5 were sent to psychiatric institutions specifically for PMDD
- 29 out of 32 participants were prescribed antidepressants or SSRIs, but many reported only partial symptomatic relief from first-line treatments
- Participants who used second- or third-line treatments (including chemical or surgical menopause) reported experiencing more functionality or complete symptom relief compared to first-line treatments
Methods, briefly
Qualitative phenomenological study using a feminist framework. N=32 in-depth semi-structured interviews (approximately 1 hour each) conducted via Zoom or phone in July 2021. Participants recruited through IAPMD online forums and snowball sampling. Inclusion criteria: self-identified as having PMDD, U.S. resident, aged 18+. Thematic analysis conducted by 6 coders using MaxQDA software with inductive and deductive coding methods. A conceptual model (PMDD Care Continuum) was developed from participant experiences.
Limitations to keep in mind
- Sample lacked racial diversity (94% White) and socioeconomic diversity
- Difficulty recruiting participants without an official PMDD diagnosis, limiting the range of diagnostic experiences captured
- Intercoder reliability scores were not formally calculated
- Self-selection bias from recruiting through PMDD community forums, potentially capturing more engaged or severe cases
- Participants self-identified as having PMDD regardless of official diagnosis, so clinical confirmation was not verified for all participants
The latest PMDD research, in your pocket
The app’s research feed is updated daily with newly published, peer-reviewed PMDD work - summarized in plain language.